Clinical Trial Update: Pragmatic RCT of High-dose Oral Montelukast for Moderate and Severe Pediatric Acute Asthma Exacerbations [Phase 2]

View source ↗

Summary

A Phase 2 pragmatic randomized trial evaluating high-dose montelukast for moderate to severe pediatric acute asthma exacerbations has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Asthma; Status, Asthma in Children | Phase 2 | Status: WITHDRAWN